GraniteShares YieldBOOST CRCL 

$24.46
8
-$0.57-2.27% Friday 20:00

統計

當日最高
24.93
當日最低
24.44
52週高點
25.92
52週低點
24.44
成交量
11,300
平均成交量
-
市值
961.55M
本益比
-
股息殖利率
5.79%
股息
1.42

即將到來

股息

5.79%股息殖利率
May 26
$0.48
May 26
$0.48
May 26
$0.46
10年成長
不適用
5年成長
不適用
3年成長
不適用
1年成長
不適用

財報

9Feb預期
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
-0.18
-0.03
0.11
0.26
預期EPS
-0.1
實際EPS
不適用

其他人也在關注

此清單是根據在 Stock Events 上追蹤 CRY 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. It offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, pulmonary, and general surgical applications; On-X prosthetic aortic and mitral heart valve, and On-X ascending aortic prosthesis; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita OPEN PLUS and E-vita OPEN NEO, a hybrid stent graft system. The company also provides E-xtra DESIGN ENGINEERING products for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system. In addition, it offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; and cardiac laser therapy products, such as SolarGen 2100s Console and SoloGrip III disposable handpieces. Further, the company sells CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as offers pyrolytic carbon coating services to other medical device manufacturers. The company serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion Inc. in January 2022. Artivion Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia.
Show more...
執行長
員工
1200
國家
美國
ISIN
US38747T6661

上市

0 Comments

分享你的想法

FAQ

GraniteShares YieldBOOST CRCL 今天的股價是多少?
CRY 目前價格為 $24.46 USD,過去 24 小時下跌了 -2.27%。在圖表上更密切關注 GraniteShares YieldBOOST CRCL 股票的表現。
GraniteShares YieldBOOST CRCL 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,GraniteShares YieldBOOST CRCL 的股票以代號 CRY 進行交易。
GraniteShares YieldBOOST CRCL 的市值是多少?
今天 GraniteShares YieldBOOST CRCL 的市值為 961.55M
GraniteShares YieldBOOST CRCL 會發放股息嗎?
是的,CRY 的股息每 每週 發放一次。每股最新股息為 0.48 USD。截至今日,股息殖利率(FWD)% 為 5.79%。
GraniteShares YieldBOOST CRCL 有多少名員工?
截至 May 26, 2026,公司共有 1,200 名員工。
GraniteShares YieldBOOST CRCL 位於哪個產業?
GraniteShares YieldBOOST CRCL從事於Other產業。
GraniteShares YieldBOOST CRCL 何時完成拆股?
GraniteShares YieldBOOST CRCL 最近沒有進行任何拆股。